Steven Gannon serves as Executive at Xenon Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Steven Gannon has executed 11 insider transactions totaling $830.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 4, 2024 involved selling 56,400 shares valued at $0.
Steven Gannon currently holds 14,000 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Gannon has been a net seller of XENE stock. They have purchased $229.2K and sold $601.6K worth of shares.
Steven Gannon's most recent insider trade was on Jun 4, 2024, when they sold 56,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $46.45 |
| Discretionary |
| Mar 7, 2024 | XENE | $92.4K | Sale | 2,000 | $46.20 | Discretionary |
| Mar 7, 2024 | XENE | $231.3K | Sale | 5,000 | $46.25 | Discretionary |
| Mar 7, 2024 | XENE | $231.5K | Sale | 5,000 | $46.30 | Discretionary |
| Aug 11, 2022 | FUSN | $90.1K | Purchase | 44,400 | $2.03 | Discretionary |
| Aug 23, 2021 | FUSN | $22.6K | Purchase | 2,829 | $7.99 | Discretionary |
| Aug 19, 2021 | FUSN | $24.1K | Purchase | 3,000 | $8.05 | Discretionary |
| Aug 18, 2021 | FUSN | $1.4K | Purchase | 171 | $8.05 | Discretionary |
| Aug 16, 2021 | FUSN | $48.6K | Purchase | 6,000 | $8.10 | Discretionary |
| Aug 11, 2017 | XENE | $42.3K | Purchase | 15,000 | $2.82 | Discretionary |